glp 1 agonist hypothyroidism Glucagon-like peptide receptor use and risk of thyroid cancer: Scandinavian cohort study GLP-1 medications can be powerful
Description
Nonetheless, for new GLP-1 drugs in development, it is imperative to evaluate potential drug interactions since this drug class can alter the efficacy of concomitant medications or increase the risk of adverse events as a result of higher exposure to a co-administrated drug
L-type calcium channels open more readily, allowing more calcium to flow into the cell
doi: 10.1210/en.2014-1675
Nature 546 , 118123 (2017)
This context is important because it underscores that the hair loss is primarily about the weight loss itself, not the specific medication
doi:10.1152/ajpendo.00298.2020 125
